Showing results (161-170 of 258) with videos related to

Sort By:
Pageof 26
Lung Cancer (Amsterdam, Netherlands)|July 2, 2021
Survival benefit of osimertinib combination therapy in patients with T790M-positive non-small-cell lung cancer refractory to osimertinib treatmentPo-Lan Su, Jeng-Shiuan Tsai, Szu-Chun Yang, et al.
Iscience|July 8, 2022
Plasma contains ultrashort single-stranded DNA in addition to nucleosomal cell-free DNAJordan Cheng, Marco Morselli, Wei-Lun Huang, et al.
Cancer Causes & Control : CCC|June 26, 2012
Risk factors for primary lung cancer among never smokers by gender in a matched case-control studyYen-Li Lo, Chin-Fu Hsiao, Gee-Chen Chang, et al.
Lung Cancer (Amsterdam, Netherlands)|November 25, 2010
Polymorphisms of MLH1 and MSH2 genes and the risk of lung cancer among never smokersYen-Li Lo, Chin-Fu Hsiao, Yuh-Shan Jou, et al.
Lung Cancer (Amsterdam, Netherlands)|December 17, 2009
ATM polymorphisms and risk of lung cancer among never smokersYen-Li Lo, Chin-Fu Hsiao, Yuh-Shan Jou, et al.
Cancers|July 30, 2020
Ultra-Short Circulating Tumor DNA (usctDNA) in Plasma and Saliva of Non-Small Cell Lung Cancer (NSCLC) PatientsFeng Li, Fang Wei, Wei-Lun Huang, et al.
BMC Cancer|August 13, 2024
Erdafitinib in Asian patients with advanced solid tumors: an open-label, single-arm, phase IIa trialJoon Oh Park, Yin-Hsun Feng, Wu-Chou Su, et al.
Cancer Science|November 29, 2019
Phase 1 study of capmatinib in MET-positive solid tumor patients: Dose escalation and expansion of selected cohortsYung-Jue Bang, Wu-Chou Su, Martin Schuler, et al.
JTO Clinical and Research Reports|September 30, 2021
Phase 1b Open-Label Trial of Afatinib Plus Xentuzumab (BI 836845) in Patients With EGFR Mutation-Positive NSCLC After Progression on EGFR Tyrosine Kinase InhibitorsKeunchil Park, Daniel Shao Weng Tan, Wu-Chou Su, et al.
Oncotarget|July 23, 2014
Chronic treatment with cisplatin induces replication-dependent sister chromatid recombination to confer cisplatin-resistant phenotype in nasopharyngeal carcinomaWen-Pin Su, Sen-Huei Hsu, Cheng-Kuei Wu, et al.
Pageof 26